Seven people die from rare blood clots after Oxford-AstraZeneca vaccine

Seven people have died of blood clotting according to the Oxford-AstraZeneca in the UK.

The Medicines and Health Products Regulatory Agency reported that people sadly died of rare blood clotting syndrome after 30 cases of rare blood clot events after using the AstraZeneca Covid-19 vaccine from regulators.

However, it is still unknown whether it was a fluke or a real side effect of the vaccine.

The MHRA said Thursday there had been “22 reports of cerebral venous sinus thrombosis (CVST) and 8 reports of other low platelet thrombosis events”.

The MHRA, the European Medicines Agency and the World Health Organization have all stated that the vaccine’s benefits in preventing Covid-19 far outweigh the potential risk of blood clots. reports the mirror.

Paul Hunter, professor of medicine at the University of East Anglia, emphasized that vaccine-related deaths are still very rare.

“The risk of death is still much greater for people who are not vaccinated than for people who received the (Oxford) vaccine,” he told The Guardian.

“It wouldn’t stop me from my next dose.”

Some countries are restricting the use of the AstraZeneca vaccine while others have restarted vaccinations as research into reports of rare and sometimes severe blood clots continues.

Germany, France, the Netherlands and Canada only restricted the use of the vaccine in the elderly.

On March 18, the UK Medicines Agency announced that there had been five cases of a rare cerebral blood clot in 11 million shots administered.

As of Thursday, 22 reports of cerebral venous sinus thrombosis (CVST), an extremely rare coagulation disorder of the brain, and 8 reports of other coagulation events related to low blood platelets were counted from a total of 18.1 million doses administered.

Dr. June Raine, the executive director of the MHRA, said the agency is looking into the reports but the vaccinations are continuing.

“The benefits of the AstraZeneca Covid-19 vaccine in preventing Covid-19 infection and its complications continue to outweigh any risks and the public should continue to receive their vaccine when prompted,” she said.

The type of clot found is unusual, with low levels of platelets and rare antibodies in the blood that have been linked to other bleeding disorders.

Prof. David Werring of the UCL Institute of Neurology told the BBC that “urgent” research needs to be done to determine whether this means that the vaccine is causally linked to the clots.

The researchers are trying to find out how common CVST clots are. Estimates range from two cases per million people per year to nearly 16 per million in normal times.

The coronavirus has been linked to abnormal clotting, making it unclear what impact the Oxford-AstraZeneca sting had on the numbers.


Leave a Comment